Well have the latest on this big storm bearing down just a week before the election. Folks, we have our october surprise. Its name is sandy. Good morning from cincinnati. 11 days till election day, friday, october 26th, 2012. This is the daily rundown. Im chuck todd and im still living on the air in cincinnati. So lets get right to my first read. President obama wrapped up a 48hour, 8state battleground blitz in cleveland late last night and with a hoarse voice went after a message hes been dealing all week long. Romneys trustworthiness. Trust matters. You know what, ohio, after all these years, you now know me. You know that i mean what i say. And almost the exactly same moment 150 mys west mitt romney took the starj in one of the great names in battleground politics, defiance, ohio, and he borrowed a page from the president s 2008 page book calling himself the president of change. This is a time when america faces big challenges. We have a big election and we want a president who will
Goodwin, Covington shepherd Biogen s $1 8bn acquisition of rare disease drugmaker
globallegalpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globallegalpost.com Daily Mail and Mail on Sunday newspapers.
Ohio Democratic lawmakers try to tackle transgender candidate ballot name issue: Capitol Letter
cleveland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cleveland.com Daily Mail and Mail on Sunday newspapers.
Published: January 7th, 2021
The vice chair and head of M&A discusses building the firm s biotech practice, helping Covid-19 vaccine developer Moderna grow over the years and recent transformational deals in the latest episode of the podcast.
Stuart Cable and his colleagues at Goodwin Procter LLP in Boston saw the biotechnology sector emerging across the Charles River in Cambridge, Mass., about 15 years ago, and they set out to build a law firm that could serve it. That required developing a team of highly specialized lawyers who could work on issues faced by biotech companies ranging in size from startups to multibillion-dollar public companies, Cable says in this week’s Drinks With The Deal podcast.